High Dose Botox Injection for Patients with Internal Anal Sphincter Achalasia Persistent to Posterior Internal Anal Sphincter Myectomy

Introduction: one of the most common reported chief complaints in visits to pediatricians is constipation. Although in a majority of cases with no anatomical defect, dietary manipulation, stool softeners, and oral laxatives are successful, some patients fail to respond. Internal Anal Sphincter (I...

Full description

Bibliographic Details
Main Authors: Leily Mohajerzadeh, Amirmohammad Zakeri, Mehdi Zanganeh kia, Ahmad Khaleghnejad Tabari, Naghi Dara
Format: Article
Language:English
Published: Pediatric Surgery Research Center of Shahid Beheshti University of Medical Sciences 2020-12-01
Series:Iranian Journal of Pediatric Surgery
Subjects:
Online Access:https://journals.sbmu.ac.ir/irjps/article/view/31946
_version_ 1818446187442733056
author Leily Mohajerzadeh
Amirmohammad Zakeri
Mehdi Zanganeh kia
Ahmad Khaleghnejad Tabari
Naghi Dara
author_facet Leily Mohajerzadeh
Amirmohammad Zakeri
Mehdi Zanganeh kia
Ahmad Khaleghnejad Tabari
Naghi Dara
author_sort Leily Mohajerzadeh
collection DOAJ
description Introduction: one of the most common reported chief complaints in visits to pediatricians is constipation. Although in a majority of cases with no anatomical defect, dietary manipulation, stool softeners, and oral laxatives are successful, some patients fail to respond. Internal Anal Sphincter (IAS) Achalasia is one of the causes of constipation.It results in failure of IAS relaxation and has similar clinical presentation to Hirschsprung’s disease with absence of rectosphincteric inhibitory reflex on anorectal manometry (ARM) and presence of ganglion cells on rectal biopsy. Although posterior internal anal sphincter myectomy (ISM) is considered the standard treatment for IASA, some cases fail to respond and present with intractable constipation which may be associated with soiling. This research aims to assess the role of botox injection for treatment of patients who presented with intractable constipation and have already beentreated by posterior IAS myectomy. Materials and Methods:Internal anal sphincter Botox injection was performed (with a dose of 20 U/Kg) in 14 patients with internal anal sphincter achalasia (IASA); who had presented with intractable constipationafter being treated by posterior internal anal sphincter myectomy. Patients were followed for 2 years after injection. Result: of all 14 patients with persistent constipation (resistant to oral laxatives), 12 patients (85.7%) had regular bowel function for more than 6 months after botox injection therapy (P < 0.05). Of all 14 patients that had needed rectal enema for defecation, no patient needed rectal enema after botox injection therapy (P < 0.05). Of 5 patients with fecal soiling before botox injection therapy (4 had occasionalsoiling, and 1 had soiling every day without social problems) only a single patient experienced transient fecal soiling for 2 weeks after botox injection therapy (P < 0.05). No patient needed another botox injection in 2 years of follow up. Conclusion: IAS Botox injection therapy (BIT) was successfully used to manage IASA patients who had presented with intractable constipation after posterior myectomy. This method significantly reduces the need for laxatives and rectal enema; and improves constipation, fecal soiling and bowel movements at the same time.
first_indexed 2024-12-14T19:43:44Z
format Article
id doaj.art-be8664eb8748453f8f49c413857962ee
institution Directory Open Access Journal
issn 2423-7612
language English
last_indexed 2024-12-14T19:43:44Z
publishDate 2020-12-01
publisher Pediatric Surgery Research Center of Shahid Beheshti University of Medical Sciences
record_format Article
series Iranian Journal of Pediatric Surgery
spelling doaj.art-be8664eb8748453f8f49c413857962ee2022-12-21T22:49:38ZengPediatric Surgery Research Center of Shahid Beheshti University of Medical SciencesIranian Journal of Pediatric Surgery2423-76122020-12-0162667310.22037/irjps.v6i2.3194631946High Dose Botox Injection for Patients with Internal Anal Sphincter Achalasia Persistent to Posterior Internal Anal Sphincter MyectomyLeily MohajerzadehAmirmohammad ZakeriMehdi Zanganeh kiaAhmad Khaleghnejad TabariNaghi DaraIntroduction: one of the most common reported chief complaints in visits to pediatricians is constipation. Although in a majority of cases with no anatomical defect, dietary manipulation, stool softeners, and oral laxatives are successful, some patients fail to respond. Internal Anal Sphincter (IAS) Achalasia is one of the causes of constipation.It results in failure of IAS relaxation and has similar clinical presentation to Hirschsprung’s disease with absence of rectosphincteric inhibitory reflex on anorectal manometry (ARM) and presence of ganglion cells on rectal biopsy. Although posterior internal anal sphincter myectomy (ISM) is considered the standard treatment for IASA, some cases fail to respond and present with intractable constipation which may be associated with soiling. This research aims to assess the role of botox injection for treatment of patients who presented with intractable constipation and have already beentreated by posterior IAS myectomy. Materials and Methods:Internal anal sphincter Botox injection was performed (with a dose of 20 U/Kg) in 14 patients with internal anal sphincter achalasia (IASA); who had presented with intractable constipationafter being treated by posterior internal anal sphincter myectomy. Patients were followed for 2 years after injection. Result: of all 14 patients with persistent constipation (resistant to oral laxatives), 12 patients (85.7%) had regular bowel function for more than 6 months after botox injection therapy (P < 0.05). Of all 14 patients that had needed rectal enema for defecation, no patient needed rectal enema after botox injection therapy (P < 0.05). Of 5 patients with fecal soiling before botox injection therapy (4 had occasionalsoiling, and 1 had soiling every day without social problems) only a single patient experienced transient fecal soiling for 2 weeks after botox injection therapy (P < 0.05). No patient needed another botox injection in 2 years of follow up. Conclusion: IAS Botox injection therapy (BIT) was successfully used to manage IASA patients who had presented with intractable constipation after posterior myectomy. This method significantly reduces the need for laxatives and rectal enema; and improves constipation, fecal soiling and bowel movements at the same time.https://journals.sbmu.ac.ir/irjps/article/view/31946internal anal sphincterachalasiaconstipationmyectomybotulinum toxinhirschsprung’s disease
spellingShingle Leily Mohajerzadeh
Amirmohammad Zakeri
Mehdi Zanganeh kia
Ahmad Khaleghnejad Tabari
Naghi Dara
High Dose Botox Injection for Patients with Internal Anal Sphincter Achalasia Persistent to Posterior Internal Anal Sphincter Myectomy
Iranian Journal of Pediatric Surgery
internal anal sphincter
achalasia
constipation
myectomy
botulinum toxin
hirschsprung’s disease
title High Dose Botox Injection for Patients with Internal Anal Sphincter Achalasia Persistent to Posterior Internal Anal Sphincter Myectomy
title_full High Dose Botox Injection for Patients with Internal Anal Sphincter Achalasia Persistent to Posterior Internal Anal Sphincter Myectomy
title_fullStr High Dose Botox Injection for Patients with Internal Anal Sphincter Achalasia Persistent to Posterior Internal Anal Sphincter Myectomy
title_full_unstemmed High Dose Botox Injection for Patients with Internal Anal Sphincter Achalasia Persistent to Posterior Internal Anal Sphincter Myectomy
title_short High Dose Botox Injection for Patients with Internal Anal Sphincter Achalasia Persistent to Posterior Internal Anal Sphincter Myectomy
title_sort high dose botox injection for patients with internal anal sphincter achalasia persistent to posterior internal anal sphincter myectomy
topic internal anal sphincter
achalasia
constipation
myectomy
botulinum toxin
hirschsprung’s disease
url https://journals.sbmu.ac.ir/irjps/article/view/31946
work_keys_str_mv AT leilymohajerzadeh highdosebotoxinjectionforpatientswithinternalanalsphincterachalasiapersistenttoposteriorinternalanalsphinctermyectomy
AT amirmohammadzakeri highdosebotoxinjectionforpatientswithinternalanalsphincterachalasiapersistenttoposteriorinternalanalsphinctermyectomy
AT mehdizanganehkia highdosebotoxinjectionforpatientswithinternalanalsphincterachalasiapersistenttoposteriorinternalanalsphinctermyectomy
AT ahmadkhaleghnejadtabari highdosebotoxinjectionforpatientswithinternalanalsphincterachalasiapersistenttoposteriorinternalanalsphinctermyectomy
AT naghidara highdosebotoxinjectionforpatientswithinternalanalsphincterachalasiapersistenttoposteriorinternalanalsphinctermyectomy